Last reviewed · How we verify

NCT05216458

Using Personalized Letters and Emails to Increase Health Insurance Take-up and Improve Plan Choice Quality

Completed NA Last updated 31 January 2022
What this trial tests

NA trial testing Emails and letter intervention in Health Behavior in 44,000 participants. Completed in 31 August 2021.

Timeline
27 May 2021
Primary endpoint
31 August 2021
31 August 2021

Quick facts

Lead sponsorOffice of Evaluation Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment44,000
Start date27 May 2021
Primary completion31 August 2021
Estimated completion31 August 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Office of Evaluation Sciences

Who can join

Eligibility, any sex, with Health Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With the passage of the American Rescue Plan (ARP) in March 2021, more consumers than ever before are now eligible for $0 -- or $1 per member per month (PMPM) in Marketplaces that include abortion coverage -- health insurance coverage across the ACA Marketplaces. But many individuals may not be aware of the new subsidies, or of their eligibility for Cost-Sharing Reduction (CSR) Silver plans. This project's goal is to examine whether personalized letters and email reminders can increase health insurance enrollment, CSR Silver take-up and $1 PMPM coverage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Health Behavior

Currently open trials in the same condition.

Other Office of Evaluation Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05216458.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing